Immunotherapy with biodegradable nanoparticles encapsulating the oligosaccharide galactose-alpha-1,3-galactose enhance immune tolerance against alpha-gal sensitization in a murine model of alpha-gal…

Overview of attention for article published in Frontiers in Allergy, August 2024

Altmetric Badge

Mentioned by

news: 10 news outlets
blogs: 1 blog

twitter: 3 X users
facebook: 1 Facebook page

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 34,883 followers.

Therapeutic potential of NP-αGal to reduce AGS in recipients with pre-existing disease. @AlphaGal_RES @alphagal_info @twoalphagals @TBCU2018 @RavelHealth #alphagal https://t.co/NKEWiBtBE9

10 Sep 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Immunotherapy with biodegradable nanoparticles encapsulating the oligosaccharide galactose-alpha-1,3-galact…

10 Aug 2024

Reply Repost Favourite

New Research: Immunotherapy with biodegradable nanoparticles encapsulating the oligosaccharide galactose-alpha-1,3-galactose enhance immune tolerance against alpha-gal sensitization in a murine model of alpha-gal syndrome https://t.co/Oi5Heiad7K #Frontiers

10 Aug 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.